Is In8bioInc Stock a Good Investment?
In8bioInc Investment Advice | INAB |
- Examine In8bioInc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research In8bioInc's leadership team and their track record. Good management can help In8bioInc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact In8bioInc's business and its evolving consumer preferences.
- Compare In8bioInc's performance and market position to its competitors. Analyze how In8bioInc is positioned in terms of product offerings, innovation, and market share.
- Check if In8bioInc pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about In8bioInc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in In8bioInc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if In8bioInc is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine In8bioInc Stock
Researching In8bioInc's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 23.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.94. Some equities with similar Price to Book (P/B) outperform the market in the long run. In8bioInc recorded a loss per share of 0.9. The entity had not issued any dividends in recent years.
To determine if In8bioInc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding In8bioInc's research are outlined below:
| In8bioInc has some characteristics of a very speculative penny stock | |
| In8bioInc had very high historical volatility over the last 90 days | |
| In8bioInc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In8bioInc currently holds about 25.74 M in cash with (23.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| In8bioInc has a poor financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company shares are held by company insiders | |
| Latest headline from investorplace.com: INAB Stock Earnings IN8bio Misses EPS for Q1 2024 |
In8bioInc Quarterly Liabilities And Stockholders Equity |
|
In8bioInc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in In8bioInc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to In8bioInc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact In8bioInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises In8bioInc's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-10 | 2024-03-31 | -0.18 | -0.2 | -0.02 | 11 | ||
2021-11-10 | 2021-09-30 | -0.28 | -0.25 | 0.03 | 10 | ||
2023-03-30 | 2022-12-31 | -0.32 | -0.37 | -0.05 | 15 | ||
2022-11-10 | 2022-09-30 | -0.29 | -0.34 | -0.05 | 17 | ||
2022-03-17 | 2021-12-31 | -0.26 | -0.21 | 0.05 | 19 | ||
2024-03-14 | 2023-12-31 | -0.15 | -0.21 | -0.06 | 40 | ||
2022-08-12 | 2022-06-30 | -0.29 | -0.38 | -0.09 | 31 | ||
2021-09-10 | 2021-06-30 | -0.4 | -0.55 | -0.15 | 37 |
Know In8bioInc's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as In8bioInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading In8bioInc backward and forwards among themselves. In8bioInc's institutional investor refers to the entity that pools money to purchase In8bioInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2023-12-31 | 49 K | Two Sigma Investments Llc | 2023-12-31 | 42.3 K | Laird Norton Tyee Trust Co | 2023-12-31 | 42.3 K | Overbrook Management Corp | 2023-12-31 | 33.8 K | Millennium Management Llc | 2024-03-31 | 32.6 K | Blackrock Inc | 2023-12-31 | 28.8 K | Renaissance Technologies Corp | 2023-12-31 | 19.6 K | Wela Strategies | 2024-03-31 | 18.5 K | Westside Investment Management, Inc. | 2023-12-31 | 14.5 K | Aigh Capital Management, Llc | 2023-12-31 | 4.1 M | Vanguard Group Inc | 2024-03-31 | 1.4 M |
In8bioInc's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate In8bioInc's market, we take the total number of its shares issued and multiply it by In8bioInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
In8bioInc's profitablity analysis
In8bioInc's profitability indicators refer to fundamental financial ratios that showcase In8bioInc's ability to generate income relative to its revenue or operating costs. If, let's say, In8bioInc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, In8bioInc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of In8bioInc's profitability requires more research than a typical breakdown of In8bioInc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.89) | (0.93) | |
| Return On Capital Employed | (1.07) | (1.12) | |
| Return On Assets | (0.89) | (0.93) | |
| Return On Equity | (1.20) | (1.14) |
Determining In8bioInc's profitability involves analyzing its financial statements and using various financial metrics to determine if In8bioInc is a good buy. For example, gross profit margin measures In8bioInc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of In8bioInc's profitability and make more informed investment decisions.
The data published in In8bioInc's official financial statements usually reflect In8bioInc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of In8bioInc. For example, before you start analyzing numbers published by In8bioInc accountants, it's critical to develop an understanding of what In8bioInc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of In8bioInc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, In8bioInc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in In8bioInc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of In8bioInc. Please utilize our Beneish M Score to check the likelihood of In8bioInc's management manipulating its earnings.
Evaluate In8bioInc's management efficiency
In8bioInc has return on total asset (ROA) of (0.7829) % which means that it has lost $0.7829 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8094) %, meaning that it created substantial loss on money invested by shareholders. In8bioInc's management efficiency ratios could be used to measure how well In8bioInc manages its routine affairs as well as how well it operates its assets and liabilities. As of May 21, 2024, Return On Tangible Assets is expected to decline to -0.93. In addition to that, Return On Capital Employed is expected to decline to -1.12. At present, In8bioInc's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 466 K, whereas Total Assets are forecasted to decline to about 25.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.83 | 0.75 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 0.83 | 0.75 | |
| Enterprise Value Over EBITDA | (0.89) | (0.94) | |
| Price Book Value Ratio | 1.65 | 1.74 | |
| Enterprise Value Multiple | (0.89) | (0.94) | |
| Price Fair Value | 1.65 | 1.74 | |
| Enterprise Value | 24.8 M | 39.9 M |
The analysis of In8bioInc's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze In8bioInc's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of In8bioInc Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.048 |
Basic technical analysis of In8bioInc Stock
As of the 21st of May, In8bioInc owns the Coefficient Of Variation of (14,747), market risk adjusted performance of (0.27), and Information Ratio of (0.02). In8bioInc technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze thirteen technical drivers for In8bioInc, which can be compared to its peers in the sector. Please check out In8bioInc information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if In8bioInc is priced some-what accurately, providing market reflects its prevailing price of 1.01 per share. Given that In8bioInc is a hitting penny stock territory we urge to closely look at its jensen alpha.In8bioInc's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific In8bioInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on In8bioInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases In8bioInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand In8bioInc's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing In8bioInc's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0048 | |||
| Market Risk Adjusted Performance | (0.27) | |||
| Mean Deviation | 3.38 | |||
| Coefficient Of Variation | (14,747) | |||
| Standard Deviation | 4.46 | |||
| Variance | 19.9 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.28) | |||
| Maximum Drawdown | 23.0 | |||
| Value At Risk | (7.20) | |||
| Potential Upside | 7.89 | |||
| Skewness | 0.6051 | |||
| Kurtosis | 0.6938 |
| Risk Adjusted Performance | 0.0048 | |||
| Market Risk Adjusted Performance | (0.27) | |||
| Mean Deviation | 3.38 | |||
| Coefficient Of Variation | (14,747) | |||
| Standard Deviation | 4.46 | |||
| Variance | 19.9 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.28) | |||
| Maximum Drawdown | 23.0 | |||
| Value At Risk | (7.20) | |||
| Potential Upside | 7.89 | |||
| Skewness | 0.6051 | |||
| Kurtosis | 0.6938 |
Consider In8bioInc's intraday indicators
In8bioInc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of In8bioInc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
In8bioInc time-series forecasting models is one of many In8bioInc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary In8bioInc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
In8bioInc Stock media impact
Far too much social signal, news, headlines, and media speculation about In8bioInc that are available to investors today. That information is available publicly through In8bioInc media outlets and privately through word of mouth or via In8bioInc internal channels. However, regardless of the origin, that massive amount of In8bioInc data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of In8bioInc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of In8bioInc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to In8bioInc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive In8bioInc alpha.
In8bioInc Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards In8bioInc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in In8bioInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
In8bioInc Corporate Management
Elected by the shareholders, the In8bioInc's board of directors comprises two types of representatives: In8bioInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of In8bioInc. The board's role is to monitor In8bioInc's management team and ensure that shareholders' interests are well served. In8bioInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, In8bioInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| TaiWei Ho | President, CoFounder | Profile | |
| William Ho | President, CoFounder | Profile | |
| Trishna MD | Chief Officer | Profile | |
| Kate Rochlin | Chief Officer | Profile | |
| Lawrence Lamb | CoFounder VP | Profile | |
| Kenneth LaMontagne | Sr Devel | Profile |
How to buy In8bioInc Stock?
To provide specific investment advice or recommendations on In8bioInc stock, we recommend investors consider the following general factors when evaluating In8bioInc. This will help you to make an informed decision on whether to include In8bioInc in one of your diversified portfolios:- Examine In8bioInc's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research In8bioInc's leadership team and their track record. Good management can help In8bioInc navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact In8bioInc's business and its evolving consumer preferences.
- Compare In8bioInc's performance and market position to its competitors. Analyze how In8bioInc is positioned in terms of product offerings, innovation, and market share.
- Check if In8bioInc pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about In8bioInc's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in In8bioInc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if In8bioInc is a good investment.
Already Invested in In8bioInc?
The danger of trading In8bioInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of In8bioInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than In8bioInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile In8bioInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether In8bioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bioinc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade In8bioInc Stock refer to our How to Trade In8bioInc Stock guide.Note that the In8bioInc information on this page should be used as a complementary analysis to other In8bioInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for In8bioInc Stock analysis
When running In8bioInc's price analysis, check to measure In8bioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bioInc is operating at the current time. Most of In8bioInc's value examination focuses on studying past and present price action to predict the probability of In8bioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bioInc's price. Additionally, you may evaluate how the addition of In8bioInc to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is In8bioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bioInc. If investors know In8bioInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Return On Assets (0.78) | Return On Equity (1.81) |
The market value of In8bioInc is measured differently than its book value, which is the value of In8bioInc that is recorded on the company's balance sheet. Investors also form their own opinion of In8bioInc's value that differs from its market value or its book value, called intrinsic value, which is In8bioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bioInc's market value can be influenced by many factors that don't directly affect In8bioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between In8bioInc's value and its price, as these two are different measures arrived at by various means. Investors typically determine if In8bioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.